Aristotle Capital Boston, LLC Catalent, Inc. Transaction History

Aristotle Capital Boston, LLC

  • $2.93 Billion
  • Q3 2024

A detailed history of Aristotle Capital Boston, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Aristotle Capital Boston, LLC holds 66,614 shares of CTLT stock, worth $4.23 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
66,614
Previous 157,166 57.62%
Holding current value
$4.23 Million
Previous $8.84 Million 54.35%
% of portfolio
0.14%
Previous 0.3%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$56.16 - $60.96 $5.09 Million - $5.52 Million
-90,552 Reduced 57.62%
66,614 $4.03 Million
Q2 2024

Aug 14, 2024
SELL
$53.58 - $57.02 $2.17 Million - $2.3 Million
-40,424 Reduced 20.46%
157,166 $8.84 Million
Q1 2024

May 15, 2024
SELL
$42.56 - $59.82 $256,807 - $360,953
-6,034 Reduced 2.96%
197,590 $11.2 Million
Q4 2023

Feb 14, 2024
SELL
$32.18 - $46.57 $573,447 - $829,877
-17,820 Reduced 8.05%
203,624 $9.15 Million
Q3 2023

Nov 14, 2023
BUY
$44.2 - $50.2 $971,604 - $1.1 Million
21,982 Added 11.02%
221,444 $10.1 Million
Q2 2023

Aug 14, 2023
BUY
$31.86 - $67.26 $199,634 - $421,451
6,266 Added 3.24%
199,462 $8.65 Million
Q1 2023

May 15, 2023
BUY
$45.44 - $74.26 $477,619 - $780,546
10,511 Added 5.75%
193,196 $12.7 Million
Q4 2022

Feb 14, 2023
SELL
$41.39 - $81.0 $308,976 - $604,665
-7,465 Reduced 3.93%
182,685 $8.22 Million
Q3 2022

Nov 14, 2022
SELL
$72.36 - $113.1 $2.57 Million - $4.02 Million
-35,585 Reduced 15.76%
190,150 $13.8 Million
Q2 2022

Aug 15, 2022
SELL
$87.2 - $114.05 $1.16 Million - $1.52 Million
-13,322 Reduced 5.57%
225,735 $24.2 Million
Q1 2022

May 16, 2022
BUY
$94.19 - $124.49 $268,818 - $355,294
2,854 Added 1.21%
239,057 $26.5 Million
Q4 2021

Feb 14, 2022
SELL
$119.57 - $139.07 $4.11 Million - $4.78 Million
-34,407 Reduced 12.71%
236,203 $30.2 Million
Q3 2021

Nov 15, 2021
BUY
$109.17 - $142.35 $17,030 - $22,206
156 Added 0.06%
270,610 $36 Million
Q2 2021

Aug 16, 2021
SELL
$100.34 - $115.69 $693,550 - $799,649
-6,912 Reduced 2.49%
270,454 $29.2 Million
Q1 2021

May 17, 2021
SELL
$101.51 - $125.27 $5.47 Million - $6.76 Million
-53,931 Reduced 16.28%
277,366 $29.2 Million
Q4 2020

Feb 22, 2021
BUY
$85.88 - $105.36 $522,322 - $640,799
6,082 Added 1.87%
331,297 $34.5 Million
Q4 2020

Feb 16, 2021
SELL
$85.88 - $105.36 $2.55 Million - $3.13 Million
-29,689 Reduced 8.37%
325,215 $33.8 Million
Q3 2020

Nov 16, 2020
SELL
$72.74 - $92.5 $1.24 Million - $1.58 Million
-17,042 Reduced 4.58%
354,904 $30.4 Million
Q2 2020

Aug 14, 2020
BUY
$48.02 - $79.04 $1.7 Million - $2.8 Million
35,467 Added 10.54%
371,946 $27.3 Million
Q1 2020

May 15, 2020
SELL
$36.95 - $62.95 $361,740 - $616,280
-9,790 Reduced 2.83%
336,479 $17.5 Million
Q4 2019

Feb 14, 2020
SELL
$47.06 - $56.64 $603,450 - $726,294
-12,823 Reduced 3.57%
346,269 $19.5 Million
Q3 2019

Nov 14, 2019
BUY
$47.45 - $58.05 $2.33 Million - $2.85 Million
49,058 Added 15.82%
359,092 $17.1 Million
Q2 2019

Mar 04, 2020
BUY
$39.26 - $54.21 $9.08 Million - $12.5 Million
231,335 Added 293.95%
310,034 $16.8 Million
Q2 2019

Aug 14, 2019
SELL
$39.26 - $54.21 $8.55 Million - $11.8 Million
-217,758 Reduced 73.45%
78,699 $4.27 Million
Q1 2019

Mar 04, 2020
BUY
$29.84 - $43.92 $6.68 Million - $9.83 Million
223,757 Added 307.78%
296,457 $12 Million
Q1 2019

May 15, 2019
BUY
$29.84 - $43.92 $110,855 - $163,162
3,715 Added 5.39%
72,700 $2.95 Million
Q4 2018

Feb 13, 2019
BUY
$29.95 - $46.34 $437,629 - $677,120
14,612 Added 26.87%
68,985 $2.15 Million
Q3 2018

Sep 16, 2019
BUY
$40.12 - $45.55 $16,930 - $19,222
422 Added 0.78%
54,373 $2.48 Million
Q3 2018

Nov 14, 2018
BUY
$40.12 - $45.55 $2.16 Million - $2.46 Million
53,951 New
53,951 $2.46 Million

Others Institutions Holding CTLT

# of Institutions
463
Shares Held
148M
Call Options Held
575K
Put Options Held
2.03M
View Full List

About Catalent, Inc.

CTLT Quotes by TradingView
  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Aristotle Capital Boston, LLC Portfolio

Follow Aristotle Capital Boston, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristotle Capital Boston, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristotle Capital Boston, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email